The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer

• मुख्य लेखकों: Yue Pan (लेखक), Yucheng Fu (लेखक), Yue Zeng (लेखक), Xiaohan Liu (लेखक), Yurong Peng (लेखक), Chunhong Hu (लेखक), Chao Deng (लेखक), Zhenhua Qiu (लेखक), Jian Zou (लेखक), Yuxuan Liu (लेखक), Fang Wu (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: BMC, 2022-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Immunotherapy has become the standard of care for non-small cell lung cancer (NSCLC), either in combination or monotherapy. However, there are still some patients who cannot benefit from it. Immunization strategies for NSCLC are based on the expression of PD-L1 on tumor cells and TMB, and a...